BIORQ
Biora Therapeutics, Inc.
Set alert
0.00 USD 0.00 0.00%
0.0001 Day range 0.0001
0.0001 52-week range 0.22
- YTD
- -99.95%
- 1 year
- -99.95%
- Open
- 0.0001
- Prev close
- 0.0001
- Mkt cap
- 452
- Vol
- 3.03K
- Avg vol
- 78
- EPS
- -0.01
- P/E
- 0.00
More statistics
- Low
- 0.0001
- High
- 0.0001
Financial health
Altman Z-Score
-109.16 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -1.7×
FY 2018 5y median -2814× FY 2023
P/S 53235×
FY 2018 5y median 20605× FY 2023
P/B -2.1×
FY 2018 5y median -591× FY 2023
P/FCF -4.4×
FY 2018 5y median -298× FY 2023
EV/EBITDA -2.1×
FY 2018 5y median -306× FY 2023
EV/Sales 61289×
FY 2018 5y median 20929× FY 2023
FCF Yield -22.8%
FY 2018 5y median -0.3% FY 2023
Profitability
Gross Margin 100.0%
FY 2018 5y median 100.0% FY 2023
Operating Margin -1678575.0%
FY 2018 5y median -9449.6% FY 2023
Net Margin -3102875.0%
FY 2018 5y median -12510.5% FY 2023
ROE 122.4%
FY 2018 5y median 176.5% FY 2023
ROIC 232.3%
FY 2018 5y median -196.9% FY 2023
ROA -397.6%
FY 2018 5y median -145.5% FY 2023
Growth (YoY)
Revenue -98.7%
FY 2018 FY 2023
Operating Income -8.7%
FY 2018 FY 2023
EPS (diluted) -1129.7%
FY 2018 FY 2023
Free Cash Flow 25.5%
FY 2018 FY 2023
Financial Health
Current Ratio 0.3×
FY 2018 5y median 1.6× FY 2023
Quick Ratio 0.3×
FY 2018 5y median 1.6× FY 2023
Debt / Equity -0.5×
FY 2018 5y median -1.3× FY 2023
Net Debt / EBITDA -0.3×
FY 2018 5y median -0.3× FY 2023
Interest Coverage -6.8×
FY 2018 5y median -9.3× FY 2023
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2023
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2023
Annual · latest fiscal year ends 2023-12-31